Mammoth Burn (powder) V2
Natural health product licensed in Canada
- Licence holder
- iNutrition Inc.
- NPN or DIN-HM
- 80069261
- Status
- Active licence
- Licence date
- 9 May 2016
- Revision date
- 15 November 2023
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Citrus aurantium L.: La quantité ingérée de p-synéphrine doit être inférieure à 20 mg par dose journalière recommandée. L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants, aux femmes enceintes ou allaitantes et en cas de traitement anti-hypertenseur. La caféine et les sources de caféine ne sont pas autorisées dans les compléments alimentaires contenant Citrus aurantium L.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Myristica fragrans Houtt.: L'huile essentielle de cette plante est interdite.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Citrus aurantium Source : Pelure (fruit) | 60 milligramme | Not calculated |
| Citrus aurantium Source : Pelure (fruit) Potency : 30 % Synephrine | Not specified | Not calculated |
| Hydroxyde de (R)-3-carboxy-2-hydroxy-N,N,N-triméthyl-1-propanaminium, Sel interne Source : L-tartrate de carnitine | 340 milligramme | Not calculated |
| Acide (S)-alpha-amino-4-hydroxybenzènepropanoïque Source : L-Tyrosine | 500 milligramme | Not calculated |
| Extrait de fève de café vert Source : Coffea canephora - Graine Extraction ratio : 1.1:1 Dry plant equivalent : 220 milligramme Potency : 45 % Chlorogenic acids | 200 milligramme | Not calculated |
| Extrait de fève de café vert Source : Coffea canephora - Graine Potency : 1 % Caffeine | Not specified | Not calculated |
| 3,7-dihydro-1,3,7-triméthyl-1H-purine-2,6-dione Source : Caféine | 156 milligramme | Not calculated |
| Olea europaea Source : Feuille Extraction ratio : 10:1 Dry plant equivalent : 1,000 milligramme Potency : 20 % Oleuropein | 100 milligramme | Not calculated |
| Myristica fragrans Source : Graine(s) | 16 milligramme | Not calculated |
Non-medicinal ingredients
Saveur de lime, Acide DL-malique, Saveur de fraise, Dioxyde de silicium, Silicate de calcium, farine de riz, Saveur de cerise, Jus de carotte violette, Saveur de limonade rose, Saveur de mangue, Saveur de pomme, Sucralose, Silice, Betterave rouge, Acésulfame-K, Saveur de punch aux fruits, Maltodextrine, Acide citrique, Stéarate de magnésium, Saveur de melon d'eau, Feuille de Stevia rebaudiana, Bêta-carotène, Saveur de framboise bleue, Saveur de pêche
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Mesures | 2 Tous les jours |
Uses authorised in Canada
Source of Tyrosine, an amino acid involved in muscle protein synthesis. Helps temporarily relieve fatigue, to promote endurance, and to enhance motor performance. Antioxidant. To be used with a program of reduced intake of dietary calories and increased physical activity (if possible) to help in weight management.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Hypersensitivity/allergy is known to occur, in which case, discontinue use. Caffeine has been shown to reduce blood flow to the heart muscle during exercise which might lead to cardiovascular complications such as chest pain, and irregular heartbeat even in healthy individuals. If those symptoms occur discontinue use and consult a health care practitioner. Allergic reactions can occur in people allergic to plants of the Oleacea family.
- Précautions et mises en garde
Ensure to adequately hydrate before, during, and after exercise. If symptoms persist or worsen, or if new symptoms develop, consult a health care practitioner. If you are taking prescription medications, or are taking other diuretics, consult a health care practitioner prior to use. If you have a liver disease, a kidney disease, or a seizure disorder, consult a healthcare practitioner prior to use. Consult a health care practitioner prior to use if you are following a low protein diet. Consult a health care practitioner prior to use if you are taking lithium. Consult a health care practitioner prior to use if you have high blood pressure, glaucoma, and/or detrusor instability. Consumption with natural health products or other drugs which increase blood pressure is not recommended. Consumption with other caffeine-containing products (e.g. medications, coffee, tea, cola, guarana, mate) is not recommended as it may increase the risk of adverse effects. This product is not intended as a substitute for sleep. Consult a health care practitioner if you are of childbearing age. Consult a health care practitioner prior to use if you have cardiovascular disease, hypertension, diabetes, or prostate disorders.
- Contre-indications
If you are pregnant or breast feeding, do not use this product. Do not consume if you are taking decongestant-containing cold preparations (i.e. phenylephrine or pseudoephedrine), products containing ephedra or ephedrine, or other medications which increase blood pressure.
Source
Official Health Canada record, licence 80069261
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2023. Photograph the packaging to check whether it has changed. Photograph the packaging